These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6418888)

  • 41. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.
    Löscher W; Czuczwar SJ
    Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
    Liu Y; Mellin C; Björk L; Svensson B; Csöregh I; Helander A; Kenne L; Andén NE; Hacksell U
    J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists.
    Grol CJ; Jansen LJ; Rollema H
    J Med Chem; 1985 May; 28(5):679-83. PubMed ID: 4039369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolved cis-10-hydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b- octahydrobenzo[f]quinoline : central serotonin stimulating properties.
    Wikström H; Andersson B; Elebring T; Jacyno J; Allinger NL; Svensson K; Carlsson A; Sundell S
    J Med Chem; 1987 Sep; 30(9):1567-73. PubMed ID: 3625704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
    Chaouloff F; Baudrie V; Layeillon C; Broqua P
    Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists.
    Kelly PA; Davis CJ; Goodwin GM
    Neuroscience; 1988 Jun; 25(3):907-15. PubMed ID: 2970017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C; Vallgårda J; Nelson DL; Björk L; Yu H; Andén NE; Csöregh I; Arvidsson LE; Hacksell U
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT.
    Emerit MB; Gozlan H; Hall MD; Hamon M; Marquet A
    Biochem Pharmacol; 1985 Mar; 34(6):883-92. PubMed ID: 3156602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
    Mignon L; Wolf WA
    Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Hacksell U; Nilsson JL; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
    J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.